Muscle Invasive Urothelial Carcinoma

Nivo, Chemoradiotherapy for Patients With nmMIBC Not Undergoing Cystectomy
The addition of nivolumab to trimodality therapy may improve relapse-free survival in patients with non-metastatic muscle-invasive bladder cancer (nmMIBC), according to results of a phase 2 randomized study by the Hellenic GU Cancer Group. Results are presented at the European Society for Medical Oncology Congress 2024. ...
Advertisement

Latest News

Advertisement

Urothelial Carcinoma Knowledge Hubs

Curated clinical content based on urothelial cancer types, therapies, and technologies

Urothelial Carcinoma
Urothelial Carcinoma

Conference Coverage

Advertisement
Section Editor

Advertisement
Get the latest bladder cancer research straight to your inbox.